MJH Associates Inc. Adds the Patient Access Network Foundation to Its Strategic Alliance Partnership Program
MJH Associates Inc., a full-service health care communications company, is expanding its Strategic Alliance Partnership (SAP) program with the addition of the Patient Access Network (PAN) Foundation. The partnership will extend across multiple MJH Associates Inc. franchises, including TheAmerican Journal of Managed Care® (AJMC®), CURE Media Group, MD Magazine®, Oncology Nursing News® (ONN®), Rare Disease Communications® and Targeted Oncology™.
In making the announcement, Michael J. Hennessy Jr., president of MJH Associates Inc., said, “We are so pleased to welcome the Patient Access Network Foundation to our SAP family. Through this partnership, we will educate providers, pharmacists, patients and their caregivers on available financial resources such as copay assistance programs, and how to manage high out-of-pocket costs. We look forward to working with all of our brands on this educational effort.”
PAN’s mission is to help underinsured people with life-threatening, chronic and rare diseases, get the medications and treatment they need by paying for their out-of-pocket costs and advocating for improved access and affordability. PAN provides financial assistance in the form of grants to eligible patients directly or through their pharmacies or providers’ offices. These grants provide access to treatment and are critically important for individuals facing high out-of-pocket costs, especially at the beginning of each calendar year as a result of high up-front deductibles.
In 2017, PAN awarded over $372 million in assistance to patients. Since 2004, PAN has helped nearly 1 million underinsured patients with more than $3 billion in copay assistance for needed treatments through their 70 disease specific programs.
“We are excited to join MJH Associates’ Strategic Alliance Partnership program to share our expertise and educate patients and caregivers, providers and pharmacies about the financial resources that are available through charitable foundations like the PAN Foundation,” said Dan Klein, PAN president and CEO. “By working with MJH and its publications and communications platforms, we have a unique opportunity to help Americans manage their out-of-pocket costs, and to create a dialogue about ways we can work together to lower these costs.”
The SAP program builds a community of advocacy groups, medical associations and medical institutions fostering collaboration and an open exchange of information for the ultimate benefit of patients and their families. It is designed to facilitate an open exchange of information among trusted peers, with the goal to improve patient care. As part of this joint effort, PAN will be able to provide expertise and share valuable content, resources, programs and awareness campaigns through AJMC®, CURE®, MD Magazine®, ONN®, Rare Disease Communication® and Targeted Oncology™. Readers will have access to unprecedented resources, including the latest interviews and articles that can help underinsured patients with life-threatening, chronic and rare diseases get the medications and treatment they need.
About MJH Associates Inc.
A full-service health care communications company offering education, research and medical media, MJH Associates Inc. is dedicated to providing health care professionals with the information and resources they need to optimize patient outcomes. The company combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and custom market research with the customer service focus and customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit http://www.mjhassoc.com.
About the Patient Access Network Foundation
The Patient Access Network (PAN) Foundation is an independent, national 501 (c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic and rare diseases with the out-of-pocket costs for their prescribed medications. Partnering with generous donors, healthcare providers and pharmacies, PAN provides the underinsured population access to the healthcare treatments they need to best manage their conditions and focus on improving their quality of life. Since its founding in 2004, PAN has provided nearly 1 million underinsured patients with over $3 billion in financial assistance, through close to 70 disease-specific programs.
About The American Journal of Managed Care ®
The American Journal of Managed Care ® (AJMC®) is a peer-reviewed, MEDLINE-indexed journal that keeps readers on the forefront of health policy by publishing research relevant to industry decision-makers as they work to promote the efficient delivery of high-quality care. AJMC.com is the essential website for managed care professionals, distributing industry updates daily to leading stakeholders. Other titles in the AJMC® family include The American Journal of Accountable Care® and two evidence-based series, Evidence-Based Oncology™ and Evidence-Based Diabetes Management™. These comprehensive offerings bring together stakeholder views from payers, providers, policymakers and other industry leaders in managed care. To order reprints of articles appearing in AJMC® publications, please contact Gil Hernandez at 609-716-7777, ext. 139.
About CURE Media Group
CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry-leading website, CUREtoday.com; innovative video programs, such as “CURE Connections®”; a series of widely attended live events; CURE® magazine, which reaches over 1 million readers; and the dynamic website for oncology nurses, https://www.OncNursingNews.com, and its companion, Oncology Nursing News® magazine. CURE Media Group is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses, which includes the acclaimed OncLive® (http://www.onclive.com) platform of resources for the practicing oncologist. For more information, visit http://www.curetoday.com or http://www.mjhassoc.com.
About MD Magazine ®
MD Magazine ® is a comprehensive clinical news and information portal that provides physicians and other health care professionals with up-to-date specialty- and disease-specific resources designed to help them deliver better care to patients. Readers have access to breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice-management updates, insight and analysis from physician contributors, and other resources. MD Magazine® is part of MJH Associates Inc., a full-service health care communications company offering education, research and medical media.
About Rare Disease Communications ®
Rare Disease Communications® is a health care communications and media company focused on the rare disease community and dedicated to raising awareness of rare diseases and orphan drugs so that patients can receive the correct diagnosis and be treated more efficiently. Rare Disease Communications® is part of the MJH Associates Inc., family of businesses, based in Cranbury, New Jersey. MJH Associates Inc. is dedicated to improving quality of life through health care education, research and communication. To learn more, visit https://www.raredr.com.
About Targeted Oncology ™
TargetedOnc.com provides the latest news and insight on next-generation therapeutics and their molecular targets for practicing oncologists. As the field of oncology continues to trend toward systemic biology and molecular aberrations, the challenge facing many oncologists is staying up-to-date with the future of cancer therapeutics. As such, TargetedOnc strives to provide the latest information on breaking news and updates on the burgeoning field. By partnering with leading oncology networks, such as the Community Oncology Alliance, Association of Community Cancer Centers and the Society for Immunotherapy of Cancer, TargetedOnc focuses on the next stage of cancer development and on cutting-edge therapies and their biological targets. Content is organized by tumor type, news and conference coverage.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181030005855/en/